Title: Further Use of Protein Kinase N Beta. Number: 20040106569. Filed: Aug. 14, 2003. Lead Inventor: Anke Klippel-Giese, Atugen.
According to the patent application's abstract, the invention "is related to the use of protein kinase N beta or a fragment or derivative thereof as a downstream target of the PI-3 kinase pathway, preferably as a downstream drug target of the PI 3-kinase pathway."
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
